Patent ID: 6172088
Filing Date: 2001-01-09
Classification: A61K,A61P

Abstract:
A method of conferring neuroprotection on a population of cells in a subject, comprising:(a) providing an effective dose of a testosterone inhibitor, wherein the testosterone inhibitor is selected from the group consisting of: a GnRH release inhibitor other than a GnRH antagonist, non-steroidal aniti-androgen, androgen synthesis inhibitor, a GnRH peptide analog, a luteinising hormone releasing hormone agonist and a 5-alpha-reductase inhibitor in a pharmaceutical formulation, wherein the testosterone inhibitor does not include either four ring cyclopentano phenanthrene compounds or estrogen compounds wherein estrogen compounds include estrogen agonists; and(b) administering the inhibitor to the subject so as to confer neuroprotection.